CeQur
CeQur provides CeQur Simplicity™, a wearable, injection-free insulin delivery device designed to simplify mealtime insulin management for people with type 1 and type 2 diabetes. The discreet device removes the pain and inconvenience of traditional injections, helping users adhere to their insulin regimen and maintain well-controlled blood glucose levels.
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Raised to date
$492MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 6 rounds
CSFHGCKCSC+3$100M · Series E
Announced Jun 2026
Disclosed cumulative: $491.6M
Founders
Founder details are not available yet.
Product
Problem
Many people with diabetes struggle to adhere to mealtime insulin regimens because traditional injections are inconvenient, painful, and interfere with daily life. This poor adherence can lead to inadequate blood glucose control and increased risk of diabetes-related complications.
Solution
CeQur offers CeQur Simplicity™, a convenient, discreet, and injection-free insulin delivery solution designed to simplify mealtime insulin management. The device removes the barriers of pain and inconvenience associated with traditional injections, allowing users to better manage their health and live life on their own terms. The product is backed by years of research, patient trials, and clinical data, supporting its effectiveness in helping users maintain well-controlled blood glucose levels.
Target Audience
Primary users are people with type 1 and type 2 diabetes who require mealtime insulin and seek an alternative to traditional injections.
Features
- Wearable, injection-free insulin delivery device for mealtime dosing
- Discreet design that minimizes interference with daily activities
- Simple, convenient operation intended to improve insulin regimen adherence
- Supported by clinical research, patient trials, and clinical data